Spinal cord stimulation uses low levels of electricity to relieve pain. A study is the first to measure this treatment’s effects on patients by gauging improvement in insomnia after spinal cord stimulation. Results showed a 30 percent or more improvement of both nighttime and daytime components of insomnia in 39.1 percent of study participants and a 30 percent or more improvement of daytime sleepiness in 28.1 percent of participants. Findings correlated with improvement in disability and depression and revealed associations with sleep and both pain and depression. Results will help clinicians gain a better understanding of the type of patient most likely to benefit from this treatment.
Tag: Spinal Cord Stimulation
AI Could Predict Ideal Chronic Pain Patients for Spinal Cord Stimulation
Spinal cord stimulation is a minimally invasive FDA-approved treatment to manage chronic pain such as back and neck pain. The ability to accurately predict which patients will benefit from this treatment in the long term is unclear and currently relies on the subjective experience of the implanting physician. A study is the first to use machine-learning algorithms in the neuromodulation field to predict long-term patient response to spinal cord stimulation.
Neuromonitoring Enables Patients to Sleep through Spinal Cord Stimulator Placement
Neuromonitoring has been used in the fields of neurological and orthopedic surgery for years but has just recently made its debut in SCS implantation. There are limited studies observing neuromonitoring in this application, so doctors have shared the case study of a patient who successfully underwent the procedure and reported 90% pain reduction one week later.
Researchers Uncover and Target Specific Proteins Linked to Pain in an Animal Model
Researchers are looking at the potential of a technique called differential target multiplexed programming (DTMP) to reduce chronic pain by targeting certain proteins linked to inflammation.
Spinal Cord Stimulation Reduces Pain and Motor Symptoms in Parkinson’s Disease Patients
A team of researchers in the United States and Japan reports that spinal cord stimulation (SCS) measurably decreased pain and reduced motor symptoms of Parkinson’s disease, both as a singular therapy and as a “salvage therapy” after deep brain stimulation (DBS) therapies were ineffective.
Best of Meeting Abstract: Neurologic Immune Cell Pathways May Offer New Target for Chronic Pain Control
According to research from investigators at Millennium Pain Center and Lumbrera, LLC, targeting of microglial activation phenotypes, such as the M1 and M2, may help control patients’ chronic pain.